|
1
|
Chen YT, Feng B and Chen LB: Update of
research on drug resistance in small cell lung cancer chemotherapy.
Asian Pac J Cancer Prev. 13:3577–3581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Sánchez Cos J, Sojo González MA,
Montero MV, Pérez Calvo MC, Vicente MJ and Valle MH: Non-small cell
lung cancer and silent brain metastasis. Survival and prognostic
factors. Lung Cancer. 63:140–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones S: An overview of the basic
helix-loop-helix proteins. Genome Biol. 5:2262004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grau R, Punzón C, Fresno M and Iñiguez MA:
Peroxisome-proliferator-activated receptor alpha agonists inhibit
cyclo-oxygenase 2 and vascular endothelial growth factor
transcriptional activation in human colorectal carcinoma cells via
inhibition of activator protein-1. Biochem J. 395:81–88. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakar Y, Duca FA, Langelier B, Devime F,
Blottiere H, Delorme C, Renault P and Covasa M: Impact of high-fat
feeding on basic helix-loop-helix transcription factors controlling
enteroendocrine cell differentiation. Int J Obes (Lond).
38:1440–1448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wushou A, Hou J, Zhao YJ and Shao ZM:
Twist-1 up-regulation in carcinoma correlates to poor survival. Int
J Mol Sci. 15:21621–21630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee SU, Song HO, Lee W, Singaravelu G, Yu
JR and Park WY: Identification and characterization of a putative
basic helix-loop-helix (bHLH) transcription factor interacting with
calcineurin in C. elegans. Mol Cells. 28:455–461. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xinghua L, Bo Z, Yan G, Lei W, Changyao W,
Qi L, Lin Y, Kaixiong T, Guobin W and Jianying C: The
overexpression of AP-4 as a prognostic indicator for gastric
carcinoma. Med Oncol. 29:871–877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu BS, Zhao G, Yu HF, Chen K, Dong JH and
Tan JW: High expression of AP-4 predicts poor prognosis for
hepatocellular carcinoma after curative hepatectomy. Tumour Biol.
34:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jackstadt R, Röh S, Neumann J, Jung P,
Hoffmann R, Horst D, Berens C, Bornkamm GW, Kirchner T, Menssen A
and Hermeking H: AP4 is a mediator of epithelial-mesenchymal
transition and metastasis in colorectal cancer. J Exp Med.
210:1331–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Zhang B, Guo Y, Liang Q, Wu C, Wu
L, Tao K, Wang G and Chen J: Down-regulation of AP-4 inhibits
proliferation, induces cell cycle arrest and promotes apoptosis in
human gastric cancer cells. PLoS One. 7:e370962012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong H, Han S, Yao H, Zhao H and Wang Y:
AP-4 predicts poor prognosis in non-small cell lung cancer. Mol Med
Rep. 10:336–340. 2014.PubMed/NCBI
|
|
14
|
Sioud M: RNA interference: Mechanisms,
technical challenges, and therapeutic opportunities. Methods Mol
Biol. 1218:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karagiannis TC and El-Osta A: siRNAs:
Mechanism of RNA interference, in vivo and potential
clinical applications. Cancer Biol Ther. 3:1069–1074. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bora RS, Gupta D, Mukkur TK and Saini KS:
RNA interference therapeutics for cancer: Challenges and
opportunities (review). Mol Med Rep. 6:9–15. 2012.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao J, Tang M, Li WL, Xie J, Du H, Tang
WB, Wang H, Chen XW, Xiao H and Li Y: Upregulation of activator
protein-4 in human colorectal cancer with metastasis. Int J Surg
Pathol. 17:16–21. 2009.PubMed/NCBI
|
|
20
|
Buechler S: Low expression of a few genes
indicates good prognosis in estrogen receptor positive breast
cancer. BMC Cancer. 9:2432009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amin S, Kumar A, Nilchi L, Wright K and
Kozlowski M: Breast cancer cells proliferation is regulated by
tyrosine phosphatase SHP1 through c-jun N-terminal kinase and
cooperative induction of RFX-1 and AP-4 transcription factors. Mol
Cancer Res. 9:1112–1125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ge Z, Zhang B, Bu X, Wang Y, Xiang L and
Tan J: Molecular mechanism of activating protein-4 regulated growth
of hepatocellular carcinoma. Tumor Biol. 35:12441–12447. 2014.
View Article : Google Scholar
|
|
23
|
Chee KG, Nguyen DV, Brown M, Gandara DR,
Wun T and Lara PN: Positron emission tomography and improved
survival in patients with lung cancer: The Will Rogers phenomenon
revisited. Arch Intern Med. 168:1541–1549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nikolov DB and Burley SK: RNA polymerase
II transcription initiation: A structural view. Proc Nat Acad Sci
USA. 94:15–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mermod N, Williams TJ and Tjian R:
Enhancer binding factors AP-4 and AP-1 act in concert to activate
SV40 late transcription in vitro. Nature. 332:557–561. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jung P and Hermeking H: The c-MYC-AP4-p21
cascade. Cell Cycle. 8:982–989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung P, Menssen A, Mayr D and Hermeking H:
AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci
USA. 105:15046–15051. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tane S, Kubota M, Okayama H, Ikenishi A,
Yoshitome S, Iwamoto N, Satoh Y, Kusakabe A, Ogawa S, Kanai A, et
al: Repression of cyclin D1 expression is necessary for the
maintenance of cell cycle exit in adult mammalian cardiomyocytes. J
Biol Chem. 289:18033–18044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms, and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta SK, Sahoo AP, Rosh N, Gandham RK,
Saxena L, Singh AK, Harish DR and Tiwari AK: Canine parvovirus NS1
induced apoptosis involves mitochondria, accumulation of reactive
oxygen species and activation of caspases. Virus Res. 213:46–61.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Do MT, Na M, Kim HG, Khanal T, Choi JH,
Jin SW, Oh SH, Hwang IH, Chung YC, Kim HS, et al: Ilimaquinone
induces death receptor expression and sensitizes human colon cancer
cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38
MAPK-CHOP signaling pathways. Food Chem Toxicol. 71:51–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
